Position in PFE
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$1,681,988
-$279,400 QoQ
Shares Held
69,850
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,026
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CACTI ASSET MANAGEMENT LLC holds $154,335,418 across 7 Drug Manufacturers - General names. PFE ranks #4 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
645,299 | $82,920,921 | |
| 2 | JNJ |
Johnson & Johnson
|
258,168 | $65,566,926 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
36,450 | $2,100,249 | |
| 4 | PFE |
Pfizer Inc
This page
|
69,850 | $1,681,988 | |
| 5 | LLY |
ELI LILLY & Co
|
800 | $959,544 | |
| 6 | NVO |
Novo Nordisk A S
|
16,000 | $767,040 | |
| 7 | OGN |
Organon & Co.
|
25,000 | $338,750 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,681,988 | 69,850 | Shares | Sole | 2026-07-01 | |
| 2026-03-31 | $1,961,388 | 69,850 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,739,265 | 69,850 | Shares | Sole | 2026-01-02 | |
| 2025-09-30 | $1,779,778 | 69,850 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $1,693,164 | 69,850 | Shares | Sole | 2025-07-01 | |
| 2025-03-31 | $1,769,999 | 69,850 | Shares | Sole | 2025-04-01 | |
| 2024-12-31 | $1,853,120 | 69,850 | Shares | Sole | 2025-01-02 | |
| 2024-09-30 | $2,021,459 | 69,850 | Shares | Sole | 2024-10-02 | |
| 2024-06-30 | $1,954,403 | 69,850 | Shares | Sole | 2024-07-01 | |
| 2024-03-31 | $1,938,337 | 69,850 | Shares | Sole | 2024-06-03 | |
| 2023-12-31 | $2,010,981 | 69,850 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $2,316,924 | 69,850 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $2,562,098 | 69,850 | Shares | Sole | 2023-07-03 | |
| 2023-03-31 | $2,849,880 | 69,850 | Shares | Sole | 2023-04-04 | |
| 2022-12-31 | $3,579,114 | 69,850 | Shares | Sole | 2023-01-03 | |
| 2022-09-30 | $3,056,636 | 69,850 | Shares | Sole | 2022-10-03 | |
| 2022-06-30 | $3,662,235 | 69,850 | Shares | Sole | 2022-07-01 | |
| 2022-03-31 | $3,616,134 | 69,850 | Shares | Sole | 2022-04-01 | |
| 2021-12-31 | $4,124,642 | 69,850 | Shares | Sole | 2022-01-03 | |
| 2021-09-30 | $3,004,248 | 69,850 | Shares | Sole | 2021-10-01 | |
| 2021-06-30 | $2,735,326 | 69,850 | Shares | Sole | 2021-07-01 | |
| 2021-03-31 | $2,530,665 | 69,850 | Shares | Sole | 2021-04-01 | |
| 2020-12-31 | $2,571,178 | 69,850 | Shares | Sole | 2021-01-04 | |
| 2020-09-30 | $2,563,492 | 69,850 | Shares | Sole | 2020-10-01 | |
| 2020-06-30 | $2,284,097 | 69,850 | Shares | Sole | 2020-07-02 | |
| 2020-03-31 | $2,230,940 | 68,350 | Shares | Sole | 2020-04-01 | |
| No filing history on record for this holder in this stock. | ||||||